Equitec Proprietary Markets, LLC Bristol Myers Squibb CO Transaction History

Equitec Proprietary Markets, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$61.48 - $73.72 $79,924 - $95,836	-1,300 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $69,719 - $81,276	1,300 New	1,300 $81,000
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $6,191 - $6,742	-100 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$57.74 - $65.43 $5,774 - $6,543	100 New	100 $6,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.